HemOnc Today Current Issue
The following articles appeared in the print edition of HemOnc Today.
Table of Contents
- Exposure to secondhand smoke places general public at severe health risk
-
- Will proliferative response measurement with PET change lymphoma management? Fernando Cabanillas, MD
- FDA approves dasatinib as second-line treatment for two types of leukemia
- Associations criticize new Medicare payment plan
- Consolidation with alemtuzumab improved responses in CLL
- NSAIDs may not reduce the risk of colorectal cancer in long-term smokers
- Once daily aspirin dose insufficient for platelet COX activity inhibition
- Prostate cancer vaccine improved survival in hormone-refractory disease
- Women with breast cancer can receive chemotherapy and deliver healthy children
-
- Managing oxaliplatin-induced neurotoxicity Lisa K. Lohr, PharmD, BCPS, BCOP